$599

Novo Invests in Brazil Manufacturing Facility; Teladoc Launches Cardiometabolic Health Program 

Two cardiometabolic news items have been observed: Novo Nordisk announced a $1.09B investment to boost manufacturing capacity in Brazil (view press release); and Teladoc Health announced the launch of a new cardiometabolic health program (view press release). Below, FENIX provides highlights and insights for the respective news items.

This content is for Read Less members only.
Register
Already a member? Log in here